Journal article · 2025 · Open access

SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals

Bernadeta Dadonaite, Allison R Burrell, Jenni Logue, Helen Y. Chu, Daniel C. Payne, David B Haslam, Mary Allen Staat, Jesse D. Bloom

Journal of Virology, 99(4), e0010925 · Published 25 March 2025 · DOI 10.1128/jvi.00109-25

Open full textCite this paper

In brief

“SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals” is a 2025 journal article by Bernadeta Dadonaite and 7 co-authors, published in Journal of Virology. OpenAlex counts 12 citations as of 18 November 2026, which puts it in the top 3% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Virology.

Citations
12
Most cited in
2026 (7)
Field-weighted impact
6.54
References
62
Authors
8

Abstract

The immune response to viral infection is shaped by past exposures to related virus strains, a phenomenon known as imprinting. For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), much of the population has been imprinted by a viral spike from an early strain, either through vaccination or infection during the early stages of the COVID-19 pandemic. As a consequence of this imprinting, infection with more recent SARS-CoV-2 strains primarily boosts cross-reactive antibodies elicited by the imprinting strain. Here we compare the neutralizing antibody specificities of imprinted individuals versus infants infected with a recent strain. Specifically, we use pseudovirus-based deep mutational scanning to measure how spike mutations affect neutralization by the serum antibodies of adults and children imprinted by the original vaccine versus infants with a primary infection by an XBB* variant. While the serum neutralizing activity of the imprinted individuals primarily targets the spike receptor-binding domain (RBD), the serum neutralizing activity of infants infected with only XBB* mostly targets the spike N-terminal domain. In these infants, secondary exposure to the XBB* spike via vaccination shifts more of the neutralizing activity toward the RBD, although the specific RBD sites targeted are different from imprinted adults. The dramatic differences in neutralization specificities among individuals with different exposure histories likely impact SARS-CoV-2 evolution.IMPORTANCEWe show that a person's exposure history to different SARS-CoV-2 strains strongly affects which regions on the viral spike that their neutralizing antibodies target. In particular, infants who have just been infected once with a recent viral strain make neutralizing antibodies that target different regions of the viral spike than adults or children who have been exposed to both older and more recent strains. This person-to-person heterogeneity means that the same viral mutation can have different impacts on the antibody immunity of different people.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Dadonaite, B., Burrell, A. R., Logue, J., Chu, H. Y., Payne, D. C., Haslam, D. B., Staat, M. A., & Bloom, J. D. (2025). SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals. Journal of Virology, 99(4), e0010925. https://doi.org/10.1128/jvi.00109-25

MLA 9

Dadonaite, Bernadeta, et al. “SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.” Journal of Virology, vol. 99, no. 4, 2025, p. e0010925. https://doi.org/10.1128/jvi.00109-25.

Chicago

Dadonaite, Bernadeta, Allison R Burrell, Jenni Logue, Helen Y. Chu, Daniel C. Payne, David B Haslam, Mary Allen Staat, and Jesse D. Bloom. 2025. “SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals.” Journal of Virology 99 (4): e0010925. https://doi.org/10.1128/jvi.00109-25.

Harvard

Dadonaite, B. et al. (2025) ‘SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals’, Journal of Virology, 99(4), p. e0010925. doi:10.1128/jvi.00109-25.

IEEE

B. Dadonaite et al., “SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals,” Journal of Virology, vol. 99, no. 4, p. e0010925, 2025, doi: 10.1128/jvi.00109-25.

BibTeX

@article{dadonaite2025sars,
  title     = {{SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals}},
  author    = {Dadonaite, Bernadeta and Burrell, Allison R and Logue, Jenni and Chu, Helen Y. and Payne, Daniel C. and Haslam, David B and Staat, Mary Allen and Bloom, Jesse D.},
  journal   = {Journal of Virology},
  year      = {2025},
  volume    = {99},
  number    = {4},
  pages     = {e0010925},
  doi       = {10.1128/jvi.00109-25},
  url       = {https://doi.org/10.1128/jvi.00109-25}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research

  • SARS-CoV-2
  • immune imprinting
  • neutralizing antibodies
  • antibody specificity
  • infants
  • XBB variant
  • spike protein receptor-binding domain
  • deep mutational scanning

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Dadonaite, B., Burrell, A. R., Logue, J., Chu, H. Y., Payne, D. C., Haslam, D. B., Staat, M. A., & Bloom, J. D. (2025). SARS-CoV-2 neutralizing antibody specificities differ dramatically between recently infected infants and immune-imprinted individuals. Journal of Virology, 99(4), e0010925. https://doi.org/10.1128/jvi.00109-25

How many times has this paper been cited?

12 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Virology: sign in and open the full text from this page.

Who wrote this paper?

Bernadeta Dadonaite, Allison R Burrell, Jenni Logue, Helen Y. Chu, Daniel C. Payne, David B Haslam, Mary Allen Staat, Jesse D. Bloom.

What is the DOI of this paper?

10.1128/jvi.00109-25, permanently at https://doi.org/10.1128/jvi.00109-25. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.